Yidan Hu Chenyang Lu Hui Lin
10.3389/fendo.2022.1016687
Front Endocrinol (Lausanne)
2022 Oct 7;13:1016687.
adverse event genotyping osteonecrosis steroid myopathy steroids
CC BY
https://pubmed.ncbi.nlm.nih.gov/36277691/
Muscular Diseases / chemically induced Muscular Diseases / genetics Osteonecrosis / chemically induced Osteonecrosis / genetics Osteonecrosis / pathology
Muscular Diseases / chemically induced Muscular Diseases / genetics Osteonecrosis / chemically induced Osteonecrosis / genetics Osteonecrosis / pathology Case Reports Research Support, Non-U.S. Gov't ATP Binding Cassette Transporter, Subfamily B / adverse effects ATP Binding Cassette Transporter, Subfamily B / genetics Female Glucocorticoids / adverse effects Humans Hydroxybutyrate Dehydrogenase / genetics Lactate Dehydrogenases / genetics Methylprednisolone Plasminogen Activator Inhibitor 1 / adverse effects Plasminogen Activator Inhibitor 1 / genetics Polymorphism, Genetic Steroids Glucocorticoids Plasminogen Activator Inhibitor 1 Hydroxybutyrate Dehydrogenase Methylprednisolone Steroids Lactate Dehydrogenases ABCB1 protein, human ATP Binding Cassette Transporter, Subfamily B
PMC9585659
36277691
Concurrence of osteonecrosis and steroid myopathy secondary to oral steroid therapy in a patient with ABCB1 gene polymorphisms: A case report
2022